IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 158 filers reported holding IMMUNOGEN INC in Q4 2016. The put-call ratio across all filers is 5.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,443,000 | -22.1% | 2,177,724 | +2.4% | 0.00% | 0.0% |
Q3 2016 | $5,702,000 | -12.1% | 2,127,680 | +1.1% | 0.00% | 0.0% |
Q2 2016 | $6,484,000 | -64.2% | 2,105,253 | -0.9% | 0.00% | -66.7% |
Q1 2016 | $18,097,000 | -38.3% | 2,124,044 | -1.7% | 0.00% | -40.0% |
Q4 2015 | $29,319,000 | +48.8% | 2,160,561 | +5.3% | 0.01% | +66.7% |
Q3 2015 | $19,703,000 | -40.2% | 2,052,374 | -10.4% | 0.00% | -40.0% |
Q2 2015 | $32,952,000 | +51.3% | 2,291,549 | -5.8% | 0.01% | +66.7% |
Q1 2015 | $21,774,000 | +47.2% | 2,432,888 | +0.3% | 0.00% | +50.0% |
Q4 2014 | $14,791,000 | -41.9% | 2,424,673 | +0.9% | 0.00% | -50.0% |
Q3 2014 | $25,454,000 | -12.1% | 2,403,589 | -1.7% | 0.00% | -20.0% |
Q2 2014 | $28,962,000 | -21.5% | 2,444,049 | -1.1% | 0.01% | -16.7% |
Q1 2014 | $36,887,000 | +7.1% | 2,470,653 | +5.2% | 0.01% | 0.0% |
Q4 2013 | $34,448,000 | -13.4% | 2,348,221 | +0.5% | 0.01% | -25.0% |
Q3 2013 | $39,769,000 | -0.7% | 2,336,610 | -3.2% | 0.01% | 0.0% |
Q2 2013 | $40,058,000 | – | 2,414,605 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 13,063,767 | $35,403,000 | 1.04% |
QVT Financial LP | 1,375,900 | $3,442,000 | 0.87% |
Virtus ETF Advisers LLC | 50,045 | $136,000 | 0.29% |
Fernwood Investment Management, LLC | 187,000 | $507,000 | 0.27% |
PURA VIDA INVESTMENTS, LLC | 524,600 | $1,422,000 | 0.20% |
Endurant Capital Management LP | 184,440 | $500,000 | 0.20% |
Birchview Capital, LP | 90,000 | $244,000 | 0.15% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 112,873 | $306,000 | 0.14% |
DLD Asset Management, LP | 1,239,500 | $3,347,000 | 0.12% |
DLD Asset Management, LP | 1,186,300 | $3,215,000 | 0.12% |